Novo Nordisk Wins Case Against Counterfeit Drugs in the US

BT

Kristeligt Dagblad

View article

avisendanmark.dk

View article

+2 Reposted by 2 other sources

Lean Right

Factuality

Ownership

A US appeals court has ruled that the FDA followed procedure when it removed weight loss drugs from the shortage list.

Dagens industri

Factuality

Ownership

Danish pharmaceutical company Novo Nordisk and American Eli Lilly have won a case against the FDA in a federal appeals court over the classification of the companies' best-selling diabetes and obesity drugs as scarce goods, Marketwire reports, citing Bloomberg News.

borsen.dk

Factuality

Ownership

Novo Nordisk and Eli Lilly, together with the US Food and Drug Administration, have won a case in a federal appeals court that the two pharmaceutical companies' mega-selling drugs for diabetes and obesity are no longer in short supply, Bloomberg News reports.